Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 6;22(21):12017.
doi: 10.3390/ijms222112017.

MATE-Type Proteins Are Responsible for Isoflavone Transportation and Accumulation in Soybean Seeds

Affiliations

MATE-Type Proteins Are Responsible for Isoflavone Transportation and Accumulation in Soybean Seeds

Ming-Sin Ng et al. Int J Mol Sci. .

Abstract

Soybeans are nutritionally important as human food and animal feed. Apart from the macronutrients such as proteins and oils, soybeans are also high in health-beneficial secondary metabolites and are uniquely enriched in isoflavones among food crops. Isoflavone biosynthesis has been relatively well characterized, but the mechanism of their transportation in soybean cells is largely unknown. Using the yeast model, we showed that GmMATE1 and GmMATE2 promoted the accumulation of isoflavones, mainly in the aglycone forms. Using the tobacco BrightYellow-2 (BY-2) cell model, GmMATE1 and GmMATE2 were found to be localized in the vacuolar membrane. Such subcellular localization supports the notion that GmMATE1 and GmMATE2 function by compartmentalizing isoflavones in the vacuole. Expression analyses showed that GmMATE1 was mainly expressed in the developing soybean pod. Soybean mutants defective in GmMATE1 had significantly reduced total seed isoflavone contents, whereas the overexpression of GmMATE1 in transgenic soybean promoted the accumulation of seed isoflavones. Our results showed that GmMATE1, and possibly also GmMATE2, are bona fide isoflavone transporters that promote the accumulation of isoflavones in soybean seeds.

Keywords: daidzein; genistein; glycitein; isoflavone; multidrug and toxic compound extrusion (MATE) transporter; seed; soybean.

PubMed Disclaimer

Conflict of interest statement

The authors report no declarations of interest.

Figures

Figure 1
Figure 1
Yeast uptake assay using a mixture of genistein, daidzein, and glycitein. The level of (A) genistein, (B) daidzein, (C) glycitein, or (D) total aglycone (genistein, daidzein and glycitein) was determined. Metabolites were extracted from the yeast after feeding for 24 h and analyzed using UPLC against the respective standards. Values obtained from the yeast expressing GmMATE1 or GmMATE2 were normalized to those from the empty vector control (EV) in the same experiment. Values shown were the mean of six independent experiments ± SEM. Significant differences compared to EV were determined by Mann-Whitney test. *, p < 0.05; **, p < 0.01.
Figure 2
Figure 2
Yeast uptake assay with a mixture of genistin, daidzin, and glycitin. Metabolites were extracted from the yeast after feeding for 24 h and analyzed using UPLC against the respective standards. It appeared some of the glycosides were converted to aglycones in the yeast by endogenous enzymes. Values obtained from the yeast expressing GmMATEs were normalized to those from the empty vector control (EV) in the same experiment. The relative uptake levels of individual isoflavone species (AC,EG) and different isoflavone combinations (D,H,IL) were determined. Total aglycones (D) refers to the combination of genistein, daidzein, and glyciteins. Total glycosides (H) refers to the combination of genistin, daidzin, and glycitin. The relative uptake level of total aglycones and glycosides is shown in (L). Values shown are the mean of six independent experiments ± SEM. Significant differences compared to EV were determined by Mann-Whitney test. *, p < 0.05; **, p < 0.01; ns, not significant.
Figure 3
Figure 3
Subcellular localizations of GmMATE1-YFP and GmMATE2-YFP were determined using confocal microscopy. The cells were incubated with FMTM4-64 in the dark at room temperature for 24 h before imaging. DIC, differential interference contrast. Signals from GmMATE-YFP and FMTM4-64 were illustrated in green and magenta, respectively.
Figure 4
Figure 4
Relative expressions of GmMATE1 and GmMATE2 in different tissues within the developing soybean seed pod. The relative expression of (A) GmMATE1 and (B) GmMATE2 in different tissues of the developing pod, normalized to the reference gene, VPS, using the 2−ΔCt method. DAF, days after flowering. Values shown are the averages of three technical replicates ± SEM. Similar expression trends were obtained in another biological repeat. (C,D) Photos showing the GUS staining of (C) transgenic soybean pods and (D) transgenic A. thaliana expressing β-glucuronidase (GUS) driven by the native GmMATE1C08 promoter. Similar results were obtained from two independent transgenic lines. Scale bar = 1 cm.
Figure 5
Figure 5
GmMATE1 is responsible for determining seed isoflavone contents. (A) The total isoflavone contents in the CRISPR/Cas9-edited GmMATE1 mutant was significantly lower than those in its wild-type, W82. Values shown were the means of at least three independently collected batches of seeds ± SEM. Significant differences were determined by Mann-Whitney test. *, p < 0.05. (B) The mutation site in the GmMATE1C08 gene, with the single-nucleotide deletion marked with an asterisk. (C) The levels of isoflavones in the transgenic soybean overexpressing GmMATE1C08 were significantly higher than those in the empty vector control, both in the W82 background. Values shown were the means of four independently collected batches of seeds ± SEM. Significant differences were determined by Mann-Whitney test. *, p < 0.05. (D) Relative expression levels of GmMATE1 in the GmMATE1C08-overexpressor and the empty vector control in the W82 background. The expression levels were normalized to the reference gene, VPS, using the 2ΔΔCt method.

References

    1. Wu A.H., Ziegler R.G., Nomura A.M.Y., West D.W., Kolonel L.N., Horn-Ross P.L., Hoover R.N., Pike M.C. Soy intake and risk of breast cancer in Asians and Asian Americans. Am. J. Clin. Nutr. 1998;68:1437S–1443S. doi: 10.1093/ajcn/68.6.1437S. - DOI - PubMed
    1. Levis S., Strickman-Stein N., Ganjei-Azar P., Xu P., Doerge D.R., Krischer J. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: A randomized, double-blind trial. Arch. Intern. Med. 2011;171:1363–1369. doi: 10.1001/archinternmed.2011.330. - DOI - PubMed
    1. Morris C., Thorpe J., Ambrosio L., Santin M. The soybean isoflavone genistein induces differentiation of MG63 human osteosarcoma osteoblasts. J. Nutr. 2006;136:1166–1170. doi: 10.1093/jn/136.5.1166. - DOI - PubMed
    1. Tadaishi M., Nishide Y., Tousen Y., Kruger M.C., Ishimi Y. Cooperative effects of soy isoflavones and carotenoids on osteoclast formation. J. Clin. Biochem. Nutr. 2014;54:109–115. doi: 10.3164/jcbn.13-94. - DOI - PMC - PubMed
    1. Green N.S., Foss T.R., Kelly J.W. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Proc. Natl. Acad. Sci. USA. 2005;102:14545–14550. doi: 10.1073/pnas.0501609102. - DOI - PMC - PubMed

LinkOut - more resources